期刊文献+

急性放射病的分度和治疗——介绍美国国家战略储备辐射工作组关于急性放射病治疗的建议之二 被引量:6

Degree and therapy of acute radiation syndromes——Introduction of a suggestion on acute radiation sickness therapy made by strategic national stockpile radiation working group of USA. Part 2
下载PDF
导出
摘要 根据受照剂量和生理反应所制定的造血综合征治疗方案包括造血因子治疗、输血以及选择病例的干细胞移植。其他医学治疗措施根据临床征兆和症状的发展而定,包括使用抗生素(奎诺酮,抗滤过性病原体治疗和抗真菌制剂),止吐剂和止痛剂。由于辐射造成的强烈的心理冲击,无论照射剂量多大,对于那些受照者以及家属和朋友都要给予社会心理支持。孕妇的医学处理必须考虑对胎儿的危害。在涉及放射性碘的恐怖袭击和偶然事故中,预防照射引起的甲状腺恶性病变的措施也包括在建议之中,儿童和青少年更是重点预防对象。 Recommendations based on radiation dose and physiologic response are made for treatment of the hematopoietic syndrome. Therapy includes treatment with hematopoietic cytokines, blood transfusion, and stem-cell transplantation in selected cases. Additional medical management based on the evolution of clinical signs and symptoms includes the use of antimicrobial agents (quinolones, antiviral therapy, and antifungal agents ), antiemetic agents, and analgesic agents. Because of the strong psychological impact of a possible radiation exposure, psychosocial support will be required for those exposed, regardless of the dose, as well as for family and friends. Treatment of pregnant women must account for risk to the fetus. For terrorist or accidental events involving exposure to radioiodines, prophylaxis against malignant disease of the thyroid is also recommended, particularly for children and adolescents.
出处 《国外医学(放射医学核医学分册)》 2005年第6期272-278,共7页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词 急性放射病 治疗 心理支持 甲状腺 acute radiation syndrome therapy psychosocial support thyroid
  • 相关文献

参考文献11

  • 1Bedell C. Pegfilgrastim for chemotherapy-induced neutropenia [J].Clin J Oncol Nurs, 2003, 7(1): 55-56.
  • 2Holmes FA, O'Shaughnessy JA, Vukelja S, et al. Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage Ⅱ or stage Ⅲ/Ⅳ breast cancer [J]. J Clin Oncol, 2002, 20(3): 727-731.
  • 3Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions [J]. JAMA, 2003, 289(15): 1941-1949.
  • 4Blajchman MA. Immunomodulation and blood transfusion [J]. Am J Ther, 2002, 9(5):389-395.
  • 5Maekawa K. Overview of medical care for highly exposed victims in the Tokaimura accident [A]. Ricks RC, Berger ME, O'Hara FM, eds.The Medical Basis for Radiation Accident Preparedness: The Clinical Care of Victims [C]. New York: Parthenon, 2002.313-318.
  • 6Fliedner TM, Graessle D, Reimers K, et al. Stem cell transplantation in radiation accidents[A]. Medical Aspects of Radiation Emergency: The Criticality Accident in Tokaimura. Chiba [C]. Japan:National Institute of Radiological Sciences, 2000. 228-235.
  • 7Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].Clin Infect Dis, 2002, 34(6):730-751.
  • 8Hughes WT. Use of antimicrobial agents for treatment of infection in the neutropenic immunocompromised patient [A]. Ricks RC, Berger ME, O'Hara FM, et al. The Medical Basis for Radiation-Accident Preparedness. The Clinical Care of Victims [C]. Washington DC:Parthenon, 2002. 117-129.
  • 9Brook I, Elliott TB, Ledney GD, et al. Management of postirradiation sepsis [J]. Mil Med, 2002, 167(2 suppl): 105-106.
  • 10National council on Radiation Protection and Measurements.Management of Terrorist Events Involving Radioactive Material.NCRP Report No. 138 [C]. Bethesda, MD, 2001. 125-134.

同被引文献92

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部